Primary Site >> Stomach Cancer
Gene >> AES
| 1. | |||||||||||
| Journal: | Gan To Kagaku Ryoho. 2008 Nov;35(12):2060-2. | ||||||||||
| Title: | [A case of unresectable advanced gastric cancer successfully treated with continuous S-1 + CPT-11 chemotherapy accompanied by dose reduction against grade 4 hematological adverse event]. | ||||||||||
| Author: | Miyazaki, Yasuhiro|Imamura, Hiroshi|Kishimoto, Tomono|Furukawa, Hiroshi|Ota, Katsuya|Tatsuta, Masayuki | ||||||||||
| PMID: | 19106523 | ||||||||||
| 2. | |||||||||||
| Journal: | Oncol Rep. 2009 Apr;21(4):1061-6. | ||||||||||
| Title: | Clinical comparison of QOL and adverse events during postoperative adjuvant chemotherapy in outpatients with node-positive colorectal cancer or gastric cancer. | ||||||||||
| Author: | Mukai, Masaya|Kishima, Kyoko|Uchiumi, Fumino|Ishibashi, Emi|Fukasawa, Maki|Tajima, Takayuki|Nakamura, Masato|Makuuchi, Hiroyasu | ||||||||||
| PMID: | 19288009 | ||||||||||
| 3. | |||||||||||
| Journal: | Tumour Biol. 2014 Apr;35(4):3283-93. | ||||||||||
| Title: | S-1-based therapy versus S-1 monotherapy in advanced gastric cancer: a meta-analysis. | ||||||||||
| Author: | Wu, Jun-Rong|Tang, Wei-Zhong|Chen, Xi|Xie, Yan-Tong|Chen, Si-Yuan|Peng, Qi-Liu|Xie, Li|Deng, Yan|Li, Tai-jie|He, Yu|Wang, Jian|Li, Shan|Qin, Xue | ||||||||||
| PMID: | 24390661 | ||||||||||
| 4. | |||||||||||
| Journal: | Beijing Da Xue Xue Bao Yi Xue Ban. 2014 Feb 18;46(1):144-8. | ||||||||||
| Title: | [Efficacy of albumin-bound paclitaxel in advanced gastric cancer patients]. | ||||||||||
| Author: | Gong, Ji-fang|Lu, Ming|Li, Jie|Li, Yan|Zhou, Jun|Lu, Zhi-hao|Wang, Xi-cheng|Li, Jian|Zhang, Xiao-tian|Shen, Lin | ||||||||||
| PMID: | 24535367 | ||||||||||
| 5. | |||||||||||
| Journal: | Mol Clin Oncol. 2014 May;2(3):466-472. | ||||||||||
| Title: | Safety and continuity of second- and third-line therapy with paclitaxel or irinotecan for advanced and recurrent gastric cancer. | ||||||||||
| Author: | Kimura, Michio|Usami, Eiseki|Kanematsu, Tetsufumi|Iwai, Mina|Yoshimura, Tomoaki|Mori, Hiromi|Sugiyama, Tadashi|Teramachi, Hitomi | ||||||||||
| PMID: | 24772319 | ||||||||||
| 6. | |||||||||||
| Journal: | Gastric Cancer. 2015 Jan;18(1):168-76. | ||||||||||
| Title: | Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study). | ||||||||||
| Author: | Shen, Lin|Li, Jin|Xu, Jianming|Pan, Hongming|Dai, Guanghai|Qin, Shukui|Wang, Liwei|Wang, Jinwan|Yang, Zhenzhou|Shu, Yongqian|Xu, Ruihua|Chen, Lei|Liu, Yunpeng|Yu, Shiying|Bu, Lilian|Piao, Yongzhe | ||||||||||
| PMID: | 24557418 | ||||||||||
| 7. | |||||||||||
| Journal: | Ann Oncol. 2015 Jan;26(1):149-56. | ||||||||||
| Title: | Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study. | ||||||||||
| Author: | Van Cutsem, E|Boni, C|Tabernero, J|Massuti, B|Middleton, G|Dane, F|Reichardt, P|Pimentel, F L|Cohn, A|Follana, P|Clemens, M|Zaniboni, A|Moiseyenko, V|Harrison, M|Richards, D A|Prenen, H|Pernot, S|Ecstein-Fraisse, E|Hitier, S|Rougier, P | ||||||||||
| PMID: | 25416687 | ||||||||||
| 8. | |||||||||||
| Journal: | Medicine (Baltimore). 2015 Apr;94(16):e652. | ||||||||||
| Title: | A Meta-analysis Reveals S-1-based Chemotherapy Improves the Survival of Patients With Advanced Gastric Cancer. | ||||||||||
| Author: | Wu, Fang-Lan|Lu, De-Cheng|Ying, Yan-Ping|Huang, Jin-Jiao|Zhou, Ai-Min|Jiang, Dun-Ke|Chen, Mao-Wei|Yang, Xi|Zhou, Jia|Huang, Hui-Qiao|Zeng, Hong-Yan | ||||||||||
| PMID: | 25906091 | ||||||||||
| 9. | |||||||||||
| Journal: | Oncologist. 2016 Sep;21(9):1085-90. | ||||||||||
| Title: | A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction. | ||||||||||
| Author: | Shah, Manish A|Cho, Jae-Yong|Tan, Iain B|Tebbutt, Niall C|Yen, Chia-Jui|Kang, Alice|Shames, David S|Bu, Lilian|Kang, Yoon-Koo | ||||||||||
| PMID: | 27401892 | ||||||||||
| 10. | |||||||||||
| Journal: | J Korean Med Sci. 2016 Sep;31(9):1355-61. | ||||||||||
| Title: | Signal Detection of Adverse Drug Reaction of Amoxicillin Using the Korea Adverse Event Reporting System Database. | ||||||||||
| Author: | Soukavong, Mick|Kim, Jungmee|Park, Kyounghoon|Yang, Bo Ram|Lee, Joongyub|Jin, Xue Mei|Park, Byung Joo | ||||||||||
| PMID: | 27510377 | ||||||||||
| 11. | |||||||||||
| Journal: | Ann Oncol. 2016 Aug;27(8):1579-85. | ||||||||||
| Title: | Efficacy of the nanoparticle-drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I-IIa clinical trial. | ||||||||||
| Author: | Keefe, S M|Hoffman-Censits, J|Cohen, R B|Mamtani, R|Heitjan, D|Eliasof, S|Nixon, A|Turnbull, B|Garmey, E G|Gunnarsson, O|Waliki, M|Ciconte, J|Jayaraman, L|Senderowicz, A|Tellez, A B|Hennessy, M|Piscitelli, A|Vaughn, D|Smith, A|Haas, N B | ||||||||||
| PMID: | 27457310 | ||||||||||
| 12. | |||||||||||
| Journal: | Oncology. 2016;90(5):248-54. | ||||||||||
| Title: | Assessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy. | ||||||||||
| Author: | Kim, Hye Ryun|Kim, Jee Hung|Rhee, Yumie|Lee, Hosun|Song, Seung Eun|Kim, Chan|Song, Sukyung|Noh, Sung Hoon|Rha, Sun Young | ||||||||||
| PMID: | 27070835 | ||||||||||
| 13. | |||||||||||
| Journal: | BMC Cancer. 2016 Jan 19;16:29. | ||||||||||
| Title: | Correlation analyses between pre- and post-operative adverse events in gastric cancer patients receiving preoperative treatment and gastrectomy. | ||||||||||
| Author: | Li, Shuang-Xi|Seo, Sang Hyuk|Choi, Yoon Young|Nakagawa, Masatoshi|An, Ji Yeong|Kim, Hyoung-Il|Cheong, Jae-Ho|Hyung, Woo Jin|Noh, Sung Hoon | ||||||||||
| PMID: | 26786480 | ||||||||||
| 14. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2017 Jan;79(1):69-79. | ||||||||||
| Title: | Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway. | ||||||||||
| Author: | He, Ming-Ming|Zhang, Dong-Sheng|Wang, Feng|Wang, Zi-Xian|Yuan, Shu-Qiang|Wang, Zhi-Qiang|Luo, Hui-Yan|Ren, Chao|Qiu, Miao-Zhen|Jin, Ying|Wang, De-Shen|Chen, Dong-Liang|Zeng, Zhao-Lei|Li, Yu-Hong|He, Yang-Yang|Hao, Yuan-Tao|Guo, Pi|Wang, Feng-Hua|Zeng, Yi- | ||||||||||
| PMID: | 27913881 | ||||||||||
| 15. | |||||||||||
| Journal: | Onco Targets Ther. 2017 Apr 26;10:2281-2287. | ||||||||||
| Title: | Treatment-related severe and fatal adverse events with molecular targeted agents in the treatment of advanced gastric cancer: a meta-analysis. | ||||||||||
| Author: | Wang, Liang|Liu, Yagang|Zhou, Wenyong|Li, Wei | ||||||||||
| PMID: | 28490885 | ||||||||||
| 16. | |||||||||||
| Journal: | J Hematol Oncol. 2017 Sep 5;10(1):153. | ||||||||||
| Title: | Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study. | ||||||||||
| Author: | Liu, Xinyang|Qin, Shukui|Wang, Zhichao|Xu, Jianming|Xiong, Jianping|Bai, Yuxian|Wang, Zhehai|Yang, Yan|Sun, Guoping|Wang, Liwei|Zheng, Leizhen|Xu, Nong|Cheng, Ying|Guo, Weijian|Yu, Hao|Liu, Tianshu|Lagiou, Pagona|Li, Jin | ||||||||||
| PMID: | 28870253 | ||||||||||
| 17. | |||||||||||
| Journal: | Oncotarget. 2017 Jun 16;8(45):79546-79555. | ||||||||||
| Title: | Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer. | ||||||||||
| Author: | Shitara, Kohei|Kim, Tae Min|Yokota, Tomoya|Goto, Masahiro|Satoh, Taroh|Ahn, Jin-Hee|Kim, Hyo Song|Assadourian, Sylvie|Gomez, Corinne|Harnois, Marzia|Hamauchi, Satoshi|Kudo, Toshihiro|Doi, Toshihido|Bang, Yung-Jue | ||||||||||
| PMID: | 29108334 | ||||||||||
| 18. | |||||||||||
| Journal: | Int J Clin Oncol. 2018 Feb;23(1):92-97. | ||||||||||
| Title: | A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma. | ||||||||||
| Author: | Murahashi, Satoshi|Takahari, Daisuke|Wakatsuki, Takeru|Fukuda, Naoki|Ichimura, Takashi|Ogura, Mariko|Ozaka, Masato|Shinozaki, Eiji|Nakayama, Izuma|Matsushima, Tomohiro|Osumi, Hiroki|Chin, Keisho|Yamaguchi, Kensei | ||||||||||
| PMID: | 28913565 | ||||||||||
| 19. | |||||||||||
| Journal: | Asia Pac J Clin Oncol. 2018 Jan 26. | ||||||||||
| Title: | Capecitabine/cisplatin versus 5-fluorouracil/cisplatin in Chinese patients with advanced and metastatic gastric cancer: Re-analysis of efficacy and safety data from the ML17032 phase III clinical trial. | ||||||||||
| Author: | Chen, Jia|Xiong, Jianping|Wang, Jiejun|Zheng, Leizhen|Gao, YanFei|Guan, Zhongzhen | ||||||||||
| PMID: | 29372626 | ||||||||||
| 20. | |||||||||||
| Journal: | Gastric Cancer. 2018 May;21(3):361-371. | ||||||||||
| Title: | The efficacy and safety of targeted therapy with or without chemotherapy in advanced gastric cancer treatment: a network meta-analysis of well-designed randomized controlled trials. | ||||||||||
| Author: | Zhao, Ting-Ting|Xu, Hao|Xu, Hui-Mian|Wang, Zhen-Ning|Xu, Ying-Ying|Song, Yong-Xi|Yin, Song-Cheng|Liu, Xing-Yu|Miao, Zhi-Feng | ||||||||||
| PMID: | 29455269 | ||||||||||
| 21. | |||||||||||
| Journal: | Clin Cancer Res. 2018 Oct 26. pii: 1078-0432.CCR-18-1337. | ||||||||||
| Title: | A Multicenter Phase 2 Study of AMG 337 in Patients With MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other Solid Tumors. | ||||||||||
| Author: | Van Cutsem, Eric|Karaszewska, Boguslawa|Kang, Yoon-Koo|Chung, Hyun Cheol|Shankaran, Veena|Siena, Salvatore|Go, Ning F|Yang, Hui|Schupp, Marco|Cunningham, David | ||||||||||
| PMID: | 30366938 | ||||||||||